Depressive Symptoms in Patients Scheduled for Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery: Prospective Associations With Morbidity and Mortality [Palliative and Supportive Care]
Conclusion
Patients with clinically significant levels of preoperative depressive symptoms are at risk for poor clinical outcomes after HIPEC + CS, including greater risk of 30-day morbidity and readmission. Further research is warranted to determine biobehavioral mechanisms and examine whether effective interventions targeting preoperative depressive symptoms can reduce postoperative risk in this patient population.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Low, Bovbjerg, Ahrendt, Alhelo, Choudry, Holtzman, Jones, Pingpank, Ramalingam, Zeh, Zureikat, Bartlett Tags: Supportive Care, Surgery, Quality of Life, Surgical Oncology Palliative and Supportive Care Source Type: research
More News: Cancer & Oncology | Chemotherapy | Depression | Epidemiology | Palliative | Palliative Care | Statistics | Study